Loading
A phase 3 trial in pancreatic cancer, run by Helsinki University Central Hospital, not yet recruiting.
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer is a phase 3, randomised interventional study registered as NCT07155629 by Helsinki University Central Hospital, with a registry enrolment figure of 381 participants, started 2025-09-01 and due to reach its primary completion in 2030-08-31. Interventions recorded: mFOLFIRINOX neoadjuvant chemotherapy / Nab-paclitaxel and gemcitabine. Conditions listed: Pancreatic Cancer Resectable. Primary outcome: Overall Survival. Pancreatic eligibility wording from the registry: "* Resectable left pancreatic cancer according to NCCN criteria". Sites: Finland. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/